Skip to content
★ Sign in to follow
石

石英秀

Board Director
Director
西点药业
Total declarations
3
Company
1
▲ Purchases (1 ops.)
€75k
▼ Sales (2 ops.)
€202k

Latest filing published 29 Aug 2025 for 西点药业.

石英秀: trading record in brief

All filings by 石英秀 on record concern 西点药业, in the capacity of board member. Between 28 July 2025 and 29 August 2025, the trades on record add up to 3 filings.

On the open market, the record shows 1 purchase worth €75k and 2 sales worth €202k. The net balance comes to €127k on the selling side. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant.

The latest filing, published on 29 August 2025, reports an open-market purchase of €75k in 西点药业. Most trades are made public on the day they happen. That lag is the time during which only the insider knows about the trade. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. Every figure here comes from the filings published by SSE / SZSE (CSRC) and describes the past, not future prices; it is not investment advice.

Companies and markets linked to 石英秀

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations3 total
  • ▲
    董事,高管Executives西点药业
    7SZSE
    20,000 sharesA股XSHESZSE:173000009476877100
    Canonical exit: 27 Nov 2025 (T+90)
  • ▼
    董事,高管Executives西点药业
    7SZSE
    21,200 sharesA股XSHESZSE:173000009412040640
  • ▼
    董事,高管Executives西点药业
    7SZSE
    30,000 sharesA股XSHESZSE:173000009292924000

3 of 3 declarations